Replies to post #2754 on ChromaDex Corp. (CDXC)

[jfk]

What everyone is thinking...What is the worst case situation that could arise from these lawsuits? Will they be able to still manufacture and market NR? Will Watson's still be supporting the global distribution of this item? Will any potential global partners (CPG ingredients, retailers, Big Pharmas) avoid any tie-ups/JV's/arrangements of any sort, in the near future, or potentially for a much longer period of time?These are all legitimate concerns. Li Ka Ching presence has mitigated them somewhat, but that may only be window dressing for the present time. The question is whether these legal entanglements are merely sand being thrown in the wheels, or if the wheels are being removed from the vehicle. In the meantime, the PE compression will be relentless. The risk/reward equation has become inverted...hopefully for merely a painful interim period, but this could drag out for ???, and share price could be dramatically affected. Will be a very difficult period to hold.

[frrol]

This lawsuit is an unfortunate distraction and waste of resources, and is because two companies weren't entirely honest with each other. Perversely though, it shows that there's a lot at stake: NR appears to be quite useful and valuable.